Literature DB >> 7520780

Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment.

J Plum1, M De Smedt, M P Defresne, G Leclercq, B Vandekerckhove.   

Abstract

Hematopoietic stem cells differentiate in the thymus to T cells along precisely defined intermediates. This process is thymic epithelium dependent and involves cytokines and cell-cell interactions between thymic stroma and T-cell precursors. Here we report that highly purified human CD34++ fetal liver stem cells differentiate to mature T cells, when seeded into isolated fetal thymic lobes of severe combined immunodeficient mice, and subsequently cultured in vitro. The human stem cells differentiate sequentially into CD4+CD8-CD3-, CD4+CD8+CD3-, CD4+CD8+CD3+, and finally, CD4+CD8-CD3+4 and CD4-CD8+CD3++ cells. Phenotypic analysis for additional maturation markers showed that these CD4 and CD8 single-positive thymocytes are fully maturate cells. By immunochemistry, human HLA-DR+ cells with a dendritic morphology could be detected. This novel chimeric human-mouse fetal thymus organ culture offers a tool to study human T-cell ontogeny in vitro and is a rapid and reliable test method for T-cell precursor activity of cultured or transfected human stem cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520780

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Expression of CD10 on lymphoid cells associated with thymoma.

Authors:  J Nakajima; S Takamoto; T Kohno; T Ohtsuka; J Matsumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-02

2.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

3.  Selection of antibodies to cell surface determinants on mouse thymic epithelial cells using a phage display library.

Authors:  D B Palmer; A J George; M A Ritter
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 4.  Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy.

Authors:  Huang Zhu; Yi-Shin Lai; Ye Li; Robert H Blum; Dan S Kaufman
Journal:  Stem Cells       Date:  2018-01-03       Impact factor: 6.277

5.  Human skin cells support thymus-independent T cell development.

Authors:  Rachael A Clark; Kei-ichi Yamanaka; Mei Bai; Rebecca Dowgiert; Thomas S Kupper
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

6.  Toward development and production of human T cells in swine for potential use in adoptive T cell immunotherapy.

Authors:  Brenda M Ogle; Bruce E Knudsen; Ryuta Nishitai; Kiyoshi Ogata; Jeffrey L Platt
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

Review 7.  Human intrathymic development: a selective approach.

Authors:  J Plum; M De Smedt; G Leclercq; T Taghon; T Kerre; B Vandekerckhove
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

8.  Diverse T-cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta-like-1-modified mouse stromal cells.

Authors:  Ekta Patel; Bei Wang; Lily Lien; Yichen Wang; Li-Jun Yang; Jan S Moreb; Lung-Ji Chang
Journal:  Immunology       Date:  2008-11-20       Impact factor: 7.397

9.  Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development.

Authors:  Kaat Durinck; Marieke Lavaert; Joni Van der Meulen; Anne-Catherine Dolens; Imke Velghe; Jelle De Medts; Karin Weening; Juliette Roels; Katrien De Mulder; Pieter-Jan Volders; Katleen De Preter; Tessa Kerre; Bart Vandekerckhove; Georges Leclercq; Jo Vandesompele; Pieter Mestdagh; Pieter Van Vlierberghe; Frank Speleman; Tom Taghon
Journal:  EMBO Rep       Date:  2020-04-07       Impact factor: 8.807

10.  Identification of lymphomyeloid primitive progenitor cells in fresh human cord blood and in the marrow of nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice transplanted with human CD34(+) cord blood cells.

Authors:  C Robin; F Pflumio; W Vainchenker; L Coulombel
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.